Penerangan
Manufacturer
Baxalta US Inc(UNITED STATES)
Registraction Number
MAL19890041AZ
Content:
- Active Ingredient: Antihemophilic Factor (Factor VIII) derived from human plasma
- Excipients: Albumin, polyethylene glycol, histidine, glycine, tri-n-butyl phosphate, octoxynol 9, and other stabilizing agents
Indication:
Hemofil-M is used for the prevention and control of hemorrhagic episodes in patients with Hemophilia A. It helps replace the missing or dysfunctional Factor VIII in the blood, which is essential for proper blood clotting.
Instructions:
- Reconstitution: Reconstitute the powder with sterile water for injection as per the instructions provided.
- Administration: Inject the reconstituted solution intravenously (IV) under the supervision of a healthcare professional.
- Dosage: The dosage is individualized based on the severity of the bleeding, the patient's weight, and the desired increase in Factor VIII levels. Typical dosages are:
- Mild hemorrhage: 20-40% Factor VIII increase
- Moderate hemorrhage: 30-60% Factor VIII increase
- Life-threatening hemorrhage: 60-100% Factor VIII increase
- Monitoring: Regular monitoring of Factor VIII levels and clinical response is necessary.
- Precautions: Inform your healthcare provider if you have any allergies, especially to mouse proteins, or if you have a history of heart disease, kidney problems, or other bleeding disorders.
Lebih maklumat tentang Complete Wellness
Malaysia
